Gyeong Sin Park
Overview
Explore the profile of Gyeong Sin Park including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
316
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Song Y, Sung Y, Beck K, Chang S, Jung J, Park G
Thorac Cancer
. 2023 Jul;
14(24):2459-2466.
PMID: 37409441
Background: Pulmonary mucosa-associated lymphoid tissue (MALT) lymphoma sometimes presents as large pulmonary nodules composed of small nodular opacities (galaxy sign) on computed tomography (CT). The aim of this study was...
2.
Kim Y, Park G, Chung Y, Lee J
J Dermatol
. 2023 Mar;
50(8):1072-1075.
PMID: 36938660
Nevus sebaceous (NS) is a congenital hamartoma associated with an increased risk of secondary neoplasms in approximately 10%-20% of patients. However, additional genomic alterations underlying tumorigenesis in NS lesions have...
3.
Kim Y, Jung S, Park Y, Park G, Kim H, Maeng L, et al.
Exp Dermatol
. 2022 Dec;
32(4):447-456.
PMID: 36533870
Actinic keratosis (AK) and cutaneous squamous cell carcinoma in situ (CIS) are two of the most common precursors of cutaneous squamous cell carcinoma (cSCC). However, the genomic landscape of AK/CIS...
4.
Kim Y, Park G, Bang C, Chung Y
J Dermatol
. 2022 Sep;
50(3):397-400.
PMID: 36117467
The genomic landscape of Bowen's disease (BD), with multiple manifestations, has not yet been determined. This study aimed to investigate the genomic alterations in multiple BD. We performed whole-exome sequencing...
5.
Kim Y, Shin S, Jung S, Park Y, Park G, Lee S, et al.
J Invest Dermatol
. 2021 Sep;
142(3 Pt A):528-538.e8.
PMID: 34480890
The mechanism underlying the progression of actinic keratosis (AK) and cutaneous squamous cell carcinoma (SCC) in situ (SCCIS) to SCC remains unclear. To investigate this, we performed regional microdissection and...
6.
Boo S, O J, Kwon S, Yoo I, Kim S, Park G, et al.
Nucl Med Mol Imaging
. 2019 Aug;
53(4):263-269.
PMID: 31456859
Purpose: F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) is the standard imaging modality for response evaluation in FDG-avid lymphoma, but the prognostic value is not established in follicular lymphoma (FL)....
7.
Hwang H, Han A, Lee J, Park G, Min W, Kim H
Immunol Invest
. 2018 Sep;
48(1):96-105.
PMID: 30204524
Previously, we found that dual therapy by the CXCR4 inhibitor Plerixafor and cytosine arabinoside (Ara-C) effectively eradicated leukemia cells and concurrently activated immune cells in acute myeloid leukemia (AML). To...
8.
Ju J, Jung M, Nam G, Kim W, Oh S, Kim H, et al.
Nat Commun
. 2018 Jan;
9(1):225.
PMID: 29335408
Whether hematopoietic cell-restricted distribution of antigens affects the degree of thymic negative selection has not been investigated in detail. Here, we show that T cells specific for hematopoietic cell-restricted antigens...
9.
Kim H, Kim Y, Lee J, Park Y, Park G, Lee J
Australas J Dermatol
. 2017 Jul;
58(3):e150-e152.
PMID: 28664615
No abstract available.
10.
Jung S, Paik J, Park G, Yang S
BMC Ophthalmol
. 2017 Apr;
17(1):59.
PMID: 28449640
Background: To report six cases of CD34+ fibroblastic mesenchymal tumours, which are uncommon neoplasms in the orbit. Case Presentation: Six patients presenting with proptosis and palpable mass who were later...